Subscribe: Market Wire - Pharmaceuticals and Biotech: Drugs
http://img.marketwire.com/rss/mwPBDR.rss
Added By: Feedage Forager Feedage Grade B rated
Language: English
Tags:
announced  announces  cannabis  company  mar  march  marketwired mar  marketwired march  marketwired  medical  new  otcqb  today 
Rate this Feed
Rate this feedRate this feedRate this feedRate this feedRate this feed
Rate this feed 1 starRate this feed 2 starRate this feed 3 starRate this feed 4 starRate this feed 5 star

Comments (0)

Feed Details and Statistics Feed Statistics
Preview: Market Wire - Pharmaceuticals and Biotech: Drugs

Marketwired - Drugs



Marketwired - Drugs



Last Build Date: Fri, 24 Mar 2017 19:05:21 EDT

Copyright: Copyright: (C) Marketwired
 



BriaCell Closes CEO Equity Investment

Fri, 24 Mar 2017 18:22:47 EDT

BERKELEY, CA and VANCOUVER, BC--(Marketwired - March 24, 2017) - BriaCell Therapeutics Corp. ("BriaCell" or the "Company") (TSX VENTURE: BCT) (OTCQB: BCTXF) is pleased to announce it has completed its previously announced non-brokered private placement financing (the "Offering") of 5,612,083 units (the "Units") for aggregate gross proceeds to the Company in the amount of $1,346,900 with its President and CEO, Dr. William Williams.




Nutritional High Clarifies Colorado Sales Update

Fri, 24 Mar 2017 17:42:05 EDT

TORONTO, ONTARIO--(Marketwired - March 24, 2017) - Nutritional High International Inc. (the "Company" or "Nutritional High") (CSE:EAT)(CSE:EAT.CN)(OTCQB:SPLIF)(FRANKFURT:2NU) wishes to clarify the Colorado sales update press release made on March 17, 2017.




BioStem Technologies, Inc. Announces Completion of 503b Pharmaceutical and Stem Cell Research Laboratory

Fri, 24 Mar 2017 14:18:03 EDT

OAKLAND PARK, FL--(Marketwired - Mar 24, 2017) -  BioStem Technologies, Inc. (OTC PINK: BSEM) ("BSEM" or "the company"), an emerging International BioTech company, celebrated the opening of its new laboratory and corporate offices with a ribbon cutting ceremony hosted by the BioStem Technologies executive team. BSEM's Founder and CEO, Henry Van Vurst, commented, "With the recent regulation changes we amended our original facility design to comply with FDA 503b regulations, which caused an extension to our timeline, but I couldn't be prouder of this new state-of-the-art facility. Cutting the ribbon with Mayor Lamar Fisher (City of Pompano Beach) was a very proud moment for the entire BSEM team, and it is a testament to how far we have come since the Company's inception in 2014."




GeoVax Reports 2016 Year-End Financial Results

Fri, 24 Mar 2017 14:00:00 EDT

ATLANTA, GA--(Marketwired - Mar 24, 2017) - GeoVax Labs, Inc. (OTCQB: GOVX), a biotechnology company developing innovative human vaccines using its novel platform technology, today announced its financial results for the year ended December 31, 2016.




NSAV Announces 2.5 Billion Share Reduction

Fri, 24 Mar 2017 10:31:40 EDT

CRESCO, PA--(Marketwired - Mar 24, 2017) - Net Savings Link, Inc. (OTC: NSAV) announced today that the Company has approved a 2.5 billion reduction of its authorized shares. The Company took this action after lengthy consultation with its attorneys, investment bankers and advisers, in order to ensure that the amount of the share reduction benefits all NSAV shareholders, while still allowing the Company to grow and make acquisitions. The Company wants to reassure all of its shareholders that no substantial dilution of its shares has taken place or will take place and that NSAV is not planning or even considering a reverse split of its shares.




Marina Biotech to Present Data on Vascular Resistance and Cancer at the Endocrine Society Annual Meeting on April 1

Fri, 24 Mar 2017 09:10:00 EDT

CITY OF INDUSTRY, CA--(Marketwired - Mar 24, 2017) - Marina Biotech, Inc. (OTCQB: MRNA), a biopharmaceutical company focused on the development and commercialization of innovative therapeutics for disease intersections of arthritis, hypertension and cancer, today announced that a new poster1 on the use of antihypertensive for the treatment of cancer by targeting vascular resistance in the tumor will be presented at the Endocrine Society Annual Meeting to be held on April 1-4, 2017, at Orange County Convention Center, Orlando, FL. 




Quadron Completes R&D for Its Automated Odor Elimination System to Eradicate Cannabis Odor

Fri, 24 Mar 2017 08:30:00 EDT

VANCOUVER, BRITISH COLUMBIA--(Marketwired - March 24, 2017) - Quadron Capital Corporation (the "Company" or "Quadron") - (CSE:QCC) - is pleased to report the completion of the research and development of its newly designed, proprietary automated Odor Elimination System ("OES") designed specifically for the industrial cannabis industry. The company believes it is the first, and most efficient solution in the market to eliminate residual odors that remain after being filtered by industry standard carbon filtration systems.




VANC Pharmaceuticals Provides Marketing Update

Fri, 24 Mar 2017 08:00:00 EDT

VANCOUVER, BRITISH COLUMBIA--(Marketwired - March 24, 2017) - VANC Pharmaceuticals Inc. ("VANC" or the "Company") (TSX VENTURE:VANC)(OTCQB:NUVPD), a pharmaceutical company focused on the Canadian generic drug and over-the-counter (the "OTC") markets provides marketing update as part of its ongoing program to bring value added products to the Canadian pharmacy industry.




Chiesi USA, Inc. Earns Triangle Business Journal's Corporate Philanthropy Award

Fri, 24 Mar 2017 08:00:00 EDT

"Chiesi in the Community" corporate social responsibility program impacts local groups, patients and employees




HempLife Today to Premiere New 24 Hour Interactive Customer Support Phone System Developed to Improve Customer Support, Customer Satisfaction, and Increase Sales Volume

Fri, 24 Mar 2017 07:30:00 EDT

DENVER, CO--(Marketwired - Mar 24, 2017) - Ubiquitech Software Corp. (OTC PINK: UBQU), through its operating subsidiary HempLife TodayT, is announcing the development and implementation of its new IVR (Interactive Voice Response), 24 hour toll-free customer support phone system, developed to improve customer support, customer satisfaction, and increase sales volume.




The Modernization of eCOA Technology for Clinical Trials, New Webinar Hosted by Xtalks

Fri, 24 Mar 2017 07:30:00 EDT

TORONTO, ON--(Marketwired - March 24, 2017) - During a live session, mobile health solution expert Mike Hughes, Senior Director of eCOA Solutions from YPrime, will provide a timely update on new industry expectations of eCOA technologies. Next generation eCOA platforms have recently evolved to support sophisticated data collection, simplify management from sponsors and sites, and improve patient compliance.




Immunovaccine to Present New Pre-clinical Combination Therapy Data at the AACR Annual Meeting

Fri, 24 Mar 2017 07:05:00 EDT

Study Designed to Assess Synergies of Combining DepoVax(TM)-based Cancer Vaccines and Novel Monoclonal Antibody Immunotherapies




Tiziana Life Sciences PLC: Exercise of Warrants & Issue of Equity

Fri, 24 Mar 2017 05:10:52 EDT

LONDON, UNITED KINGDOM--(Marketwired - Mar 24, 2017) - Tiziana Life Sciences PLC (AIM: TILS)




Diet Doc Addresses Mama June Shannon's Struggles With Emotional Eating and its Effects on Weight Gain

Fri, 24 Mar 2017 01:00:00 EDT

HOUSTON, TX--(Marketwired - March 24, 2017) - Mama June Shannon from TLC's Here Comes Honey Boo Boo has recently been in the news due to her startling weight loss. Her role on the show often featured her excessive and sometimes extreme eating habits mainly due to what she admitted to be emotional eating. Though Mama June ended up undergoing gastric bypass surgery as well as a few cosmetic procedures to foster weight loss progress, Diet Doc Medical Weight Loss urges individuals who struggle with weight loss to understand that emotional eating is a very valid and common weight loss obstacle. Emotional eating due to stress, anxiety and depressive disorders account for increased incidences on binge eating and lack of portion control. Food is a great way for may people to soothe themselves but fortunately, emotional eating habits can be tackled with solid diet planning and pharmacy-grade medications that can help to balance out one's emotions and minimize the instances of binge eating.




SNS FiRe Conference Names ElpisEremo a 2017 FiReStarter Company

Thu, 23 Mar 2017 15:13:20 EDT

Global thought leaders converge this October to address some of the world's greatest challenges




AlumiFuel Reports Preliminary Revenue Results for the Fourth Quarter of 2016

Thu, 23 Mar 2017 10:38:02 EDT

CENTENNIAL, CO--(Marketwired - Mar 23, 2017) - AlumiFuel Power Corporation (OTC PINK: AFPW) ("AlumiFuel" or the "Company") today announced preliminary revenue results for the fourth quarter of 2016.




Dr. Brita Hansen joins LogicStream Health as Chief Medical Officer

Thu, 23 Mar 2017 10:00:00 EDT

MINNEAPOLIS, MN--(Marketwired - Mar 23, 2017) - LogicStream Health, Inc. is pleased to announce Dr. Brita Hansen is the company's new Chief Medical Officer. Dr. Hansen comes to LogicStream from Hennepin County Medical Center (HCMC), where she served as Chief Health Information Officer. Prior to her role as CHIO, Dr. Hansen spent many years in quality improvement as the Medical Director of Inpatient Quality and Informatics at HCMC. She is also an assistant professor of medicine at the University of Minnesota School of Medicine.




Dr. Brita Hansen joins LogicStream Health as Chief Medical Officer

Thu, 23 Mar 2017 10:00:00 EDT

MINNEAPOLIS, MN--(Marketwired - Mar 23, 2017) -  LogicStream Health, Inc. is pleased to announce Dr. Brita Hansen is the company's new Chief Medical Officer. Dr. Hansen comes to LogicStream from Hennepin County Medical Center (HCMC), where she served as Chief Health Information Officer. Prior to her role as CHIO, Dr. Hansen spent many years in quality improvement as the Medical Director of Inpatient Quality and Informatics at HCMC. She is also an assistant professor of medicine at the University of Minnesota School of Medicine.




PCI Synthesis Wins Big at 2017 Life Science Leader Magazine CMO Leadership Awards

Thu, 23 Mar 2017 09:14:00 EDT

Wins "Top Performer" in all 14 categories




Mount Tam Biotechnologies Announces that the Japan Patent Office Has Allowed a Key Patent for Lead Compound TAM-01

Thu, 23 Mar 2017 09:00:00 EDT

NOVATO, CA--(Marketwired - Mar 23, 2017) -  Mount Tam Biotechnologies, Inc. ("Mount Tam") (OTC PINK: MNTM), a company focused on the discovery and development of novel mTOR inhibitors is pleased to announce that the Japanese Patent Office has allowed a key patent for TAM-01, a novel mTOR modulator, targeting unmet need in systemic lupus erythematosus (SLE). The patent, owned by the Buck Institute for Research on Aging and licensed exclusively to Mount Tam Biotechnologies, provides composition of matter protection for Mount Tam's lead compound in Japan, complementing Mount Tam's strong intellectual property position in the United States.




Future Farm: An Emerging Leader in Cultivation & Extraction -- CFN Media

Thu, 23 Mar 2017 09:00:00 EDT

SEATTLE, WA--(Marketwired - Mar 23, 2017) -  CFN Media Group ("CannabisFN"), the leading creative agency and digital media network dedicated to legal cannabis, announces the publication of an article discussing Future Farm Technologies Inc. (CSE: FFT) (OTCQB: FFRMF) and its recent move to build a presence in both Florida and California.




South American Gold Corp Appoints New EVP and CFO

Thu, 23 Mar 2017 08:46:02 EDT

LAS VEGAS, NV--(Marketwired - Mar 23, 2017) - South American Gold Corp (OTC PINK: SAGD) is proud to announce the appointment of its new Executive Vice-President and Chief Financial Officer.




Atossa Genetics Opens Enrollment in Study of Endoxifen

Thu, 23 Mar 2017 08:41:12 EDT

SEATTLE, WA--(Marketwired - Mar 23, 2017) - Atossa Genetics Inc. (NASDAQ: ATOS) today announced that it has opened enrollment of a Phase 1 study of endoxifen, which is an active metabolite of tamoxifen, an FDA approved drug for breast cancer. The objectives of this placebo-controlled, repeat dose study of 48 healthy female volunteers is to assess the pharmacokinetics of proprietary formulations of both oral and topical endoxifen dosage forms over 28 days, as well as to assess safety and tolerability.




American Cannabis Company, Inc. Announces It Has Secured A Contract With A New Client In The Canadian Province Of Alberta

Thu, 23 Mar 2017 08:30:00 EDT

DENVER, CO--(Marketwired - Mar 23, 2017) - American Cannabis Company, Inc. (OTCQB: AMMJ) (the "Company"), a full-service business-to-business consulting solutions provider, and seller of ancillary products to the cannabis industry, today announced it has secured its first client in the Canadian province of Alberta. The Company will be working with this client to strategically plan business operations as well as develop a robust financial model in effort to lay the foundation for license acquisition. Furthermore, the Company will be providing the Client with cultivation and manufacturing facility conceptual design work that is necessary to further advance the project build. The Company expects to leverage this contract to secure additional revenues through long-term consulting agreements and potential sales of ancillary products.




Aeolus Receives BARDA Decision Regarding Additional Options for Lung ARS Development Contract; Files Response to Assertions Made by BARDA in the Notification

Thu, 23 Mar 2017 08:00:00 EDT

MISSION VIEJO, CA--(Marketwired - March 23, 2017) - Aeolus Pharmaceuticals, Inc. (OTCQB: AOLS)




Upcoming Webinar Assessing NASH: Discover the Non-Invasive Techniques

Thu, 23 Mar 2017 07:30:00 EDT

TORONTO, ON--(Marketwired - March 23, 2017) - On Thursday, April 13, 2017, Xtalks will host a complimentary webinar featuring Dr. Richard Ehman, Professor of Radiology, Blanche R. & Richard J. Erlanger Professor of Medical Research, Mayo Clinic; President and CEO, Resoundant, Inc. and Jonathan Riek, Vice President, Musculoskeletal and Metabolic Imaging, BioTelemetry Research (Cardiocore & VirtualScopics) as the presenters.




Critical CRO Oversight Metrics: How to Establish the Right Metrics and Monitor them in Real-time, New Webinar Hosted by Xtalks

Thu, 23 Mar 2017 07:00:00 EDT

TORONTO, ON--(Marketwired - March 23, 2017) - Julie Peacock from Client Services at Comprehend and Linda Sullivan, Co-Founder & President of Metrics Champion Consortium (MCC) will provide an in-depth look at CRO oversight and risk management best practice. Their presentation delves into the gaps in oversight processes, the causes of these gaps and how to successfully address them. The live broadcast takes place on Wednesday, April 12, 2017 at 1pm EDT.




Diet Doc's Team Tackles Metabolic Syndrome With Strategic Meal Planning and Health Assessments

Thu, 23 Mar 2017 01:00:00 EDT

DETROIT, MI--(Marketwired - March 23, 2017) - Metabolic syndrome is defined by a combination of poor health factors which include, high blood pressure, high abdominal fat, uncontrolled blood sugar and high cholesterol. Unfortunately, incidences of metabolic syndrome are rising in the U.S. due to sedentary lifestyles, lack of physical activity, over consumption of snacks and other processed foods and elevated levels of stress. Tobacco and alcohol use also contributes to this growing problem. The telltale sign of metabolic syndrome is consistent weight gain or great difficulty when trying to lose weight. Usually, metabolic syndrome be the end result of a long period of having a slow-functioning metabolism that may never have been addressed.




Pieris Pharmaceuticals Reports Full-Year 2016 Financial Results and Corporate Update

Wed, 22 Mar 2017 20:18:32 EDT

Company to Host an Investor Conference Call on Thursday, March 23, 2017 at 10:00 AM EDT




CV Sciences, Inc. Applauds U.S. Department of Defense Smokeless Tobacco Cessation Campaign

Wed, 22 Mar 2017 19:00:00 EDT

Company Addresses its Lead Drug Candidate Aimed at a $2B Market Opportunity




DNA testing at BC community pharmacies comes one step closer

Wed, 22 Mar 2017 12:30:00 EDT

Research project focuses on patients on mental health medications




Science Exchange Named Finalist for Coveted Procurement Leaders World Procurement Awards

Wed, 22 Mar 2017 11:00:00 EDT

Science Exchange on Shortlist for Procurement Service Provider Award; Winners Announced in May




TissueGen Featured in Nature.com Webcast on Innovations in Drug Delivery Technology

Wed, 22 Mar 2017 10:00:00 EDT

TissueGen's ELUTE Fiber Provides Controlled Sustained Delivery of Sensitive Drugs Enabling Nerve Regeneration and Tissue Engineering




Amazonas Florestal Ltd. Announces The Company Has Inaugurated New Headquarters In The Brickell Financial District in Miami and That Its Subsidiary Amazon Hemp Ltd. Will Be Planting One Month Ahead of Schedule

Wed, 22 Mar 2017 09:51:40 EDT

Company Opens New Headquarters and Gets Set to Plant 100 Acres of Industrial CBD Hemp One Month in Advance




Moleculin Receives Orphan Drug Designation for Annamycin for the Treatment of Acute Myeloid Leukemia

Wed, 22 Mar 2017 09:35:26 EDT

HOUSTON, TX--(Marketwired - March 22, 2017) - Moleculin Biotech, Inc., (NASDAQ: MBRX) ("Moleculin" or the "Company"), a preclinical pharmaceutical company focused on the development of anti-cancer drug candidates, some of which are based on license agreements with The University of Texas System on behalf of the M.D. Anderson Cancer Center, today announced its lead candidate, Annamycin (also known as "Liposomal Annamycin"), an anthracycline, has received Orphan Drug Designation by the U.S. Food and Drug Administration (FDA) for the treatment of acute myeloid leukemia (AML).




Maple Leaf Doubles Down on ACMPR License -- CFN Media

Wed, 22 Mar 2017 09:00:00 EDT

SEATTLE, WA--(Marketwired - Mar 22, 2017) - CFN Media Group ("CannabisFN"), the leading creative agency and digital media network dedicated to legal cannabis, announces the publication of an article discussing Maple Leaf Green World Inc.'s (TSX VENTURE: MGW) (OTCQB: MGWFF) plans to obtain licensed producer status over the near-term.




InMed's Exceptional Management Team Executes Ambitious Plan -- CFN Media

Wed, 22 Mar 2017 09:00:00 EDT

SEATTLE, WA--(Marketwired - Mar 22, 2017) -  CFN Media Group ("CannabisFN"), the leading creative agency and digital media network dedicated to legal cannabis, announces the publication of an article discussing InMed Pharmaceuticals Inc.'s (CSE: IN) (OTCQB: IMLFF) exceptional management team and their unique approach to the market.




Laguna Blends Moves to Acquire Global Cannabis Leader -- CFN Media

Wed, 22 Mar 2017 09:00:00 EDT

SEATTLE, WA--(Marketwired - Mar 22, 2017) - CFN Media Group ("CannabisFN"), the leading creative agency and digital media network dedicated to legal cannabis, announces the publication of an article discussing Laguna Blends Inc.'s (CSE: LAG) (OTC PINK: LAGBF) plans to acquire a leading global cannabis firm and grow into a leader in the space.




Advantis Corp. To Introduce New Line of Concentrate-Infused Products, CEO to Be Interviewed on Small Cap Voice

Wed, 22 Mar 2017 09:00:00 EDT

NEWPORT BEACH, CA--(Marketwired - Mar 22, 2017) - ADVANTIS CORPORATION (OTC PINK: ADVT) is introducing a new line of premium concentrate-infused products that it will make available through its existing business partners, before kicking off a new marketing campaign. Advantis CEO, Christopher Swartz will comment further on this product line along with providing a future outlook and shareholder update on Small Cap Voice next week.




AssistRx Announces Patient Adherence Data: iAssist Can Dramatically Reduce Prescription Abandonment

Wed, 22 Mar 2017 08:59:16 EDT

iAssist has been proven to simplify patient access, accelerate time-to-therapy, and reduce primary nonadherence, commonly known as prescription abandonment




Wanderport Corporation Launches Online Retailing of Premium Hemp Coffee Blends on Amazon

Wed, 22 Mar 2017 08:30:00 EDT

SANTA MONICA, CA--(Marketwired - Mar 22, 2017) -  Wanderport Corporation (OTC: WDRP) is pleased to announce the Company has commenced product sales and distribution on Amazon.com, the largest Internet-based retailer in the world by total sales and market capitalization.




NEMUS Bioscience and the University of Mississippi Announce Significant Anti-MRSA Synergy Data Utilizing Proprietary Cannabinoid-Based Anti-Infective Platforms

Wed, 22 Mar 2017 08:30:00 EDT

COSTA MESA, CA--(Marketwired - Mar 22, 2017) - NEMUS Bioscience, Inc. (OTCQB: NMUS) and the company's discovery and research partner, the University of Mississippi (UM), today announced that bactericidal synergy was achieved against multiple species of methicillin-resistant Staphylococcus aureus (MRSA) utilizing a proprietary cannabinoid-based therapeutic platform. MRSA species tested included community acquired- (CA-MRSA), healthcare-acquired- (HA-MRSA), and mupirocin-resistant (MR-MRSA) strains of MRSA. 




Sipp Industries Forms Distribution Partnership with Wanderport Corporation to Supply Premium Bulk Hemp Seed and Oil

Wed, 22 Mar 2017 08:30:00 EDT

COSTA MESA, CA--(Marketwired - Mar 22, 2017) - Sipp Industries, Inc. (OTC: SIPC), a multifaceted corporation specializing in technology, manufacturing, and distribution of commercial and consumer products, is pleased to announce that upon exploration of their complementary synergies, a partnership was established to supply premium bulk hemp seed and oil for Wanderport's (OTC: WDRP) growing selection of consumer hemp based products and premium CBD and hemp coffee line.




National Brain Tumor Society Launches New Brain Tumor-Specific Clinical Trial Finder

Wed, 22 Mar 2017 08:30:00 EDT

New tool will make it easier for brain tumor patients to find up-to-date information on clinical trials, enabling patients to better engage with medical research and make more informed decisions about their own treatment options in the era of precision medicine




Marijuana Company of America Continues National Expansion with Production Permit in Adelanto, California

Wed, 22 Mar 2017 08:30:00 EDT

BONSALL, CA--(Marketwired - Mar 22, 2017) - MARIJUANA COMPANY OF AMERICA ("MCOA" or the "Company") (OTC PINK: MCOA), an innovative cannabis and hemp marketing and distribution company, is pleased to announce that it has completed due diligence and entered into a binding joint venture agreement with GateC Research, Inc. ("GCR") for the purpose of engaging in the cultivation of legal marijuana in Adelanto, California.




American Cannabis Company, Inc. Announces Successful Submission of State Application Materials For All Five Of Its Active Pennsylvania Clients

Wed, 22 Mar 2017 08:30:00 EDT

DENVER, CO--(Marketwired - Mar 22, 2017) - American Cannabis Company, Inc. (OTCQB: AMMJ) (the "Company"), a full-service business-to-business consulting solutions provider, and seller of ancillary products to the cannabis industry, today announced that five of its active clients have successfully submitted application materials and supporting documents for the purpose of acquiring business licenses to operate within the newly founded medical cannabis program that is to be regulated by the State of Pennsylvania.




Lexaria Introduces TurboCBD(TM) Brand of High Absorption Full Spectrum Hemp Oil Capsules

Wed, 22 Mar 2017 08:05:00 EDT

KELOWNA, BC--(Marketwired - March 22, 2017) - Lexaria Bioscience Corp (OTCQB: LXRP) (CSE: LXX) (CSE: LXX.CN) (CNSX: LXX) (the "Company" or "Lexaria") announces the introduction of the TurboCBDT brand of technologically enhanced, high absorption full spectrum hemp oil capsules. Lexaria's TurboCBDT capsules are specially formulated with the finest American Ginseng and Ginkgo Biloba for support of enhanced focus and memory, and reduced stress and fatigue.




MJTV Develops Two More Essential Oil Alchemys To Add On To The VOLUPTAS Project LUNA Line

Wed, 22 Mar 2017 08:00:00 EDT

WHIPPANY, NJ--(Marketwired - Mar 22, 2017) - Michael James Enterprises, Inc. (OTCQB: MJTV), is pleased to report that the company has developed two more essential oil alchemy products and is in the final test marketing for both products. This will bring MJTV essential oil product line to 3 with an additional two more essential oil mixtures to come in the near future bringing the total to 5.




Aldeyra Therapeutics Schedules Webcast and Conference Call for Full Year 2016 Financial Results

Wed, 22 Mar 2017 08:00:00 EDT

LEXINGTON, MA--(Marketwired - Mar 22, 2017) - Aldeyra Therapeutics, Inc. (NASDAQ: ALDX) (Aldeyra), a biotechnology company focused on the development of products to treat diseases related to aldehydes, today announced it will issue financial results for the year ended December 31, 2016 on Thursday, March 30, 2017, prior to the market open.




Vaxil Secures Collaboration with Clalit Meir Medical Center for its Lead Product

Wed, 22 Mar 2017 08:00:00 EDT

Collaboration to test MUC1-SP immune therapy using clinical samples from multiple cancer types




AntriaBio Appoints Two Pharmaceutical Executives to its Board of Directors

Wed, 22 Mar 2017 08:00:00 EDT

LOUISVILLE, CO--(Marketwired - March 22, 2017) - AntriaBio, Inc. ("AntriaBio or the "Company") (OTCQB: ANTB), a biopharmaceutical growth company specializing in the development of innovative drug therapies for patients with diabetes and metabolic diseases, announced today the appointment of Tae Hoon Kim and Samir R. Patel, M.D. to its Board of Directors. Mr. Kim and Dr. Patel join AntriaBio's Board as the Company prepares to conduct the first-in-human clinical study for its lead product candidate, AB101, a once-weekly basal insulin in development for patients with type 1 and type 2 diabetes.




Golden Leaf Signs Binding Letter of Agreement to Acquire Leading Oregon Cannabis Business

Wed, 22 Mar 2017 07:00:00 EDT

Canaccord Genuity Toronto to Lead Capital Raise to Fund Acquisition Strategy




Easton Pharmaceuticals Announces Advancing $300,000 Payment To CommonSense Ltd. Paving The Way For The Anticipated Closing Of Exclusive Sub-Distribution Agreement For Product AL-Sense with 2nd Quarter Launch

Wed, 22 Mar 2017 06:00:00 EDT

Announces Regulatory Update On Fast-Track Filing Of Generic Cancer Drug Paclitaxel For The Mexican Market and Latin America




A1 Group, Inc. Signs North American Licensing and Distribution Agreement with TREC Beverages, Inc.

Tue, 21 Mar 2017 17:35:03 EDT

FORT LAUDERDALE, FL--(Marketwired - Mar 21, 2017) - A1 Group, Inc. (OTC PINK: AWON) is pleased to announce that it has signed an exclusive North American licensing and distribution agreement with TREC Beverages, Inc. ("TREC Beverages"). TREC Beverages' core portfolio beverage item is the "Slow Cow®" Mind CoolerT. Slow Cow, owned by Boisson Slow Cow, Inc., is currently distributing and developing its products in 20 countries throughout the world. With their award-winning 100% natural infused sparkling water designed to help relax your mind and body, sharpen your mental focus, all without causing drowsiness.




IntelGenx to Report Fourth Quarter and Full Year 2016 Financial Results on March 28, 2017 - Conference Call to Follow

Tue, 21 Mar 2017 16:30:00 EDT

SAINT-LAURENT, QUEBEC--(Marketwired - March 21, 2017) - IntelGenx Technologies Corp., (TSX VENTURE:IGX)(OTCQX:IGXT), today announced that it will release its fourth quarter and full year 2016 financial results after market close on March 28, 2017.




LogixHealth Publishes Physician-Focused Intelligence Briefing: 2017 Emergency Department Physician Update

Tue, 21 Mar 2017 12:00:00 EDT

BEDFORD, MA--(Marketwired - Mar 21, 2017) - LogixHealth, a leading provider of internet and software enabled coding, billing, analytics and management services for hospital and physician practices nationwide, provides services for millions of Emergency Department (ED) visits nationwide, and has analyzed the implications of the Medicare 2017 Physician Fee Schedule and published its newest physician-focused Intelligence Briefing: 2017 Emergency Department Physician Update.




Average Cost of Training New Medical Information Call Center Agents Tops $16,000

Tue, 21 Mar 2017 10:22:00 EDT

RESEARCH TRIANGLE PARK, NC--(Marketwired - March 21, 2017) - The most successful pharmaceutical companies allocate an average $16,900 annually per new call center agent, according to a business intelligence study by life sciences research firm Cutting Edge Information.




NSAV Announces Major Reduction of Authorized Shares

Tue, 21 Mar 2017 10:16:21 EDT

CRESCO, PA--(Marketwired - Mar 21, 2017) - Net Savings Link, Inc. (OTC: NSAV) announced today that the Company has approved a major reduction of its authorized shares. The exact amount of the decrease will finalized in the coming days and will be publicly disclosed in a comprehensive press release within a week. The Company will be consulting with its attorneys, investment bankers and advisers, in order to ensure that the amount of the share reduction benefits all NSAV shareholders, while still allowing the Company to grow and make acquisitions. The current management of NSAV had planned a major reduction of its authorized shares, which was increased by the former management in July 2015. The Company decided to take this action and make this announcement earlier than planned in response to numerous shareholder inquiries, in which the NSAV shareholders were afraid of an immediate and substantial dilution of it shares. The Company wants to reassure all of its shareholders that no substantial dilution of its shares has taken place or will take place.




South American Gold Corp. Announces Launch of PotCircles Social Network

Tue, 21 Mar 2017 09:35:10 EDT

LAS VEGAS, NV--(Marketwired - Mar 21, 2017) - PotCircles is a product of South American Gold Corp. (OTC PINK: SAGD). PotCircles has launched its awareness campaign for the launch of its cannabis dedicated social network. This all-new social network is focused on the individuals within the cannabis community, compassion for these individuals and their lifestyles, and knowledge of the effects, benefits, and laws surrounding cannabis. This network looks to make a difference and differentiate itself from other social networks by not only celebrating a lifestyle but also becoming a platform for serious issues surrounding cannabis.




Freedom Leaf, Inc. (OTC PINK: FRLF) Makes Sharp Inroads To Increase Revenue Through Exclusive Distribution Contracts And Newly Developed Proprietary Skin Care And Breathable Vapor Product lines

Tue, 21 Mar 2017 09:33:52 EDT

LAS VEGAS, NV--(Marketwired - Mar 21, 2017) -  Freedom Leaf, Inc. (OTC PINK: FRLF) recently announced in an 8-K an important contract with NuAxon BioScience, Inc. out of Indiana, USA to be the EXCLUSIVE DISTRIBUTOR for their large capacity super critical CO2 extraction units: a product line with Extractors from $210,000 to $3 million. Freedom Leaf has exclusive distribution rights worldwide excluding India and is actively building a rep network worldwide with qualified equipment sales applicants. 




InCrowd's Janet Kosloff Named a Boston SmartCEO 2017 Future 50 Award Winner

Tue, 21 Mar 2017 09:30:00 EDT

Among 60 Greater Boston companies to be recognized for fast growth, made possible by InCrowd's real-time market intelligence platform




Future Farm Engages CFN Media to Cultivate New Investor Audience

Tue, 21 Mar 2017 09:00:00 EDT

SEATTLE, WA--(Marketwired - Mar 21, 2017) -  CFN Media Group ("CFN Media", "CannabisFN"), the leading agency and digital media network dedicated to the North American cannabis industry, today announced that Future Farm Technologies Inc. ("Future Farm") (CSE: FFT) (OTCQB: FFRMF) has engaged CFN Media to conduct a market visibility program, beginning on March 20, 2017.




Precision Therapeutic Cancer Vaccine Developer Treos Bio Opens U.S. Headquarters in San Francisco

Tue, 21 Mar 2017 08:15:00 EDT

Names Dong Wei, Ph.D., MBA, as its Chief Operating Officer




ONL Therapeutics Receives Nearly $1.0 Million Grant from National Eye Institute for Continued Advancement of ONL1204 Program

Tue, 21 Mar 2017 08:05:00 EDT

Grant Funding Combined with Recent Financing Will Support Final IND-Enabling Studies for Novel Retinal Disease Drug Candidate




MasterControl Spotlights QMS for Pharmaceutical Companies at INTERPHEX 2017

Tue, 21 Mar 2017 08:00:00 EDT

NEW YORK, NY--(Marketwired - Mar 21, 2017) - MasterControl Inc., a global provider of enterprise software solutions for life science and other regulated companies, today announced it will be highlighting the benefits of advanced quality management systems (QMS) for pharmaceutical companies at the INTERPHEX 2017 conference to be held March 21-23 in New York City.




L-DOS47 Phase I Study Results To Be Presented at the 9th International Conference of Contemporary Oncology

Tue, 21 Mar 2017 08:00:00 EDT

TORONTO, ON--(Marketwired - Mar 21, 2017) - Helix BioPharma Corp. (TSX: HBP) (FRANKFURT: HBP), a clinical stage immuno-oncology company developing innovative drug candidates for the prevention and treatment of cancer, announces that results from the Phase I L-DOS47 study will be presented at the upcoming 9th International Conference of Contemporary Oncology meeting in Poznan, Poland from the 22nd to the 24th of March, 2017. The leading theme of the conference is genome-based precision oncology -- direct targeting and immune-targeting of cancer.




ICTV Brands Inc. to Report Fourth Quarter 2016 Financial Results on March 28, 2017

Tue, 21 Mar 2017 08:00:00 EDT

Business update conference call will be held on Tuesday, March 28th, 2017 at 4:30pm ET




Canabo Medical Inc. Opens New Clinic in Chilliwack, BC

Tue, 21 Mar 2017 08:00:00 EDT

VANCOUVER, BC--(Marketwired - March 21, 2017) - Canabo Medical Inc. (TSX VENTURE: CMM) (OTCQB: CAMDF) ("Canabo" or the "Company") is pleased to announce it has opened a clinic in Chilliwack, British Columbia. The Company's BC operations will be led by Dr. Gwyllyn Goddard who has over 9 years' experience in authorizing medical cannabis, specializes in chronic disease and management and is an active researcher in the Company's current observational study. This opening represents the Company's first clinic in British Columbia and expands the Company's clinic footprint from coast-to-coast.




Aphria Continues Success Story With TSX Listing

Tue, 21 Mar 2017 08:00:00 EDT

Listing increases access to capital and growing investor base interested in burgeoning cannabis industry




Upcoming Xtalks Webinar to Examine Formulating Amorphous Solid Dispersions: Bridging Particle Engineering and Formulation

Tue, 21 Mar 2017 07:30:00 EDT

TORONTO, ON--(Marketwired - March 21, 2017) - During a live broadcast on Thursday, April 6, 2017, experts from Hovione will highlight the importance of an integrated development of both the spray dried intermediate (SDI) and the formulation. By bridging particle engineering of the drug product intermediate and the final dosage formulation, one can perform a concurrent optimization of drug performance and process performance, with respect to yield, throughput and process robustness throughout the process train. This is achieved by using QbD tools, such as Design of Experiments and mechanistic modelling, to integrate all the competing factors in formulation development, and establish the optimal processing conditions and material attributes.




Delivra Signs Exclusive Licensing Deal with Dosecann for Cannabis Oil Formulations in Metered Dose Formats

Tue, 21 Mar 2017 07:00:00 EDT

TORONTO, ON--(Marketwired - March 21, 2017) - Delivra Corp. (TSX VENTURE: DVA) ("Delivra" or the "Company"), Dosecann Inc. ("Dosecann") and ARA-Avanti Rx Analytics Inc. ("Avanti") announced today a strategic partnership to develop a unique suite of standardized products for the medical cannabis research, development, and commercialization markets.




Two Rivers To Host Investor Conference Call

Tue, 21 Mar 2017 07:00:00 EDT

DENVER, CO--(Marketwired - Mar 21, 2017) - Two Rivers Water & Farming Company ("Two Rivers") (OTCQB: TURV) is pleased to announce that it has scheduled a conference call with Two Rivers' management for potential and existing shareholders on March 30, 2017 at 4:15 P.M. EDT, just after the close of the stock market. Management will be discussing upcoming Two Rivers' developments to be made public in the days prior to the call.




La Société Hydropothecary fait Son entrée à la Bourse de croissance TSX

Tue, 21 Mar 2017 06:00:00 EDT

GATINEAU, QC --(Marketwired - 21 mars 2017) - Hydropothecary (TSX CROISSANCE: THCX) (" THC " ou l'" Entreprise ") est fière d'annoncer qu'elle fera son entrée à la Bourse de croissance TSX sous le symbole THCX lors de l'ouverture des marchés le mardi 21 mars 2017.




The Hydropothecary Corporation to Begin Trading on the TSX Venture Exchange

Tue, 21 Mar 2017 06:00:00 EDT

GATINEAU, QC--(Marketwired - March 21, 2017) - The Hydropothecary Corporation (TSX VENTURE: THCX) ("THC" or the "Company") is pleased to announce that the Company will commence trading on the TSX Venture Exchange, symbol THCX, when the market opens on Tuesday, March 21, 2017.

"Today, we are making history. As Quebec's first and only licensed producer of medical marijuana, Hydropothecary will be publicly traded on the TSX Venture Exchange for the first time," said Sebastien St-Louis, Co-Founder and Chief Executive Officer.




The 800-Calorie Diet Trend Should Only be Practiced Under Strict Medical Supervision, According to Dr. Nishant Rao

Tue, 21 Mar 2017 01:00:00 EDT

NEW ORLEANS, LA--(Marketwired - March 21, 2017) - The intention of the latest 800-Calorie Diet trend is to create caloric deficits for rapid weight loss results. For the average dieter, this could mean cutting down their caloric intake by 1000 or more calories each day. Ideally, the plan is only recommended for those who fall into the obesity category, but this hasn't prevented many who are overweight, or just needing to lose a few extra pounds from attempting the diet. The 800-Calorie diet itself has no specific regimen to follow, being that the only requirement is that one remains with in those caloric restraints. While the consumption of vegetables and fruits are recommended on the diet, there are no specific guidelines, which lead many to skimp on nutrition in order to focus on calories alone. According to health professionals, this diet falls under the very low calorie diet category.




Dr. Rao Explains that the Beyond Diet May Not Take Caloric Deficits into Account for Expedient Weight Loss

Tue, 21 Mar 2017 01:00:00 EDT

SIOUX FALLS, SD--(Marketwired - March 21, 2017) - The Beyond Diet looks to promote clean eating and avoidance of certain foods that hinder metabolic function. It is essentially, another re-hash of basic healthy eating principles based on the premise that eliminating five of the following foods: orange juice, soy milk, artificial sweetener, wheat bread and pasta will recharge the metabolism. Dr. Nishant Rao - Medical Director of Diet Doc explains that, "While this may be true for some, it certainly doesn't apply to everyone with weight management challenges, nor does the Beyond Diet offer anything particularly unique. It simply removes obviously unhealthy food and replaces it with healthier options."




Med Ad News Announces Finalists for the 2017 Manny Awards and Names Dana Maiman, CEO/President of FCB Health, as Industry Person of the Year

Mon, 20 Mar 2017 15:57:22 EDT

LIVINGSTON, NJ--(Marketwired - March 20, 2017) - Med Ad News, the leading pharmaceutical business and marketing publication, announces the nominees for the 28th Annual Manny Awards, celebrating the best in pharmaceutical and healthcare advertising, and announces Dana Maiman as the Industry Person of the Year. The Manny Awards annual gala event celebrates creative excellence in healthcare advertising and communications. More than 600 industry peers are expected to join Med Ad News in honoring winners across 20 total award categories, including the year's Most Creative Agency, Most Admired Agency, Best Launch Campaign, Agency of the Year I, II and III, and more. The Manny Awards ceremony will be held on Thursday, April 20, 2017, at Pier Sixty at Chelsea Piers in New York City.




OncBioMune Announces Term Sheet to Acquire Norepinefrine from Teva Pharmaceuticals in Mexico

Mon, 20 Mar 2017 10:07:54 EDT

BATON ROUGE, LA--(Marketwired - March 20, 2017) - OncBioMune Pharmaceuticals, Inc. (OTCQB: OBMP) ("OncBioMune" or the "Company"), a clinical stage biopharmaceutical company engaged in the development of novel cancer products and a proprietary vaccine technology, is pleased to announce the signing of a non-binding term sheet ("Term Sheet") with NYSE-listed Teva Pharmaceuticals Industries Ltd. ("Teva"), the world's largest generic medicines producer, with regards to Norepinefrine for the Mexican market. This registration can as well be used in other Central and Latin American countries and will be selected by own discretion.




GeoVax Reports Promising Results for Zika Vaccine

Mon, 20 Mar 2017 09:00:00 EDT

100% Protection Observed in Lethal Preliminary Challenge Model




eWellness Plans East Coast Regional Support Team For PT Clinic Adoption

Mon, 20 Mar 2017 09:00:00 EDT

CULVER CITY, CA--(Marketwired - Mar 20, 2017) - eWellness Healthcare Corporation (OTCQB: EWLL), a provider of the state of the art PHZIO platform for the physical therapy and telehealth markets, announced today that it plans to create a New York based regional sales, onboarding and training team to support physical therapists ("PT's") clinics in the 7 states of New York, New Jersey, Connecticut, Massachusetts, Maryland, Pennsylvania and Virginia by mid-May 2017 for its PHZIO platform.




Nemus Bioscience Signs Development Agreement with Nanomerics to Advance Ocular Formulation of NB1111 for the Treatment of Glaucoma Using Proprietary Molecular Envelope Technology (MET)

Mon, 20 Mar 2017 08:30:00 EDT

COSTA MESA, CA--(Marketwired - Mar 20, 2017) - NEMUS Bioscience, Inc. (OTCQB: NMUS) announced that the company has signed a development agreement with Nanomerics Ltd. of the United Kingdom, to develop a topical ocular formulation of tetrahydrocannabinol-valine-hemisuccinate (THCVHS), the prodrug of THC, which is the active component of Nemus drug candidate NB1111 being developed for the treatment of glaucoma. The aim of the agreement is to conduct initial studies assessing the preparation of clinical-grade eye drops using the patented Molecular Envelope Technology (MET) developed by Nanomerics. Work under the agreement will commence on a future date to be determined by Nemus in connection with its development plans and corporate objectives. 




Aphria Exercises Warrants for Gross Proceeds of $1.3 Million to Further Fund Tetra's Clinical Trials

Mon, 20 Mar 2017 08:30:00 EDT

OTTAWA, ONTARIO--(Marketwired - March 20, 2017) - Tetra Bio-Pharma Inc. ("Tetra Bio" or "the Company") (CSE:TBP)(CSE:TBP.CN)(OTC PINK:GRPOF) is pleased to announce that Aphria Inc. (TSX VENTURE:APH)(OTCQB:APHQF) has exercised their 5,000,000 warrants for aggregate gross proceeds of $1,300,000. The proceeds from the warrant exercise will be used to advance the clinical trials being developed in PhytoPain Pharma Inc., a subsidiary of Tetra.




Quadron Closes Cybernetic Control Systems Acquisition

Mon, 20 Mar 2017 08:30:00 EDT

VANCOUVER, BRITISH COLUMBIA--(Marketwired - March 20, 2017) - Quadron Capital Corp. (the "Company" or "Quadron") - (CSE:QCC)(CSE:QCC.CN) - is pleased to announce that it has closed the acquisition of Cybernetic Control Systems Inc. ("Cybernetic").




DiamiR to Present at the GTCbio Biomarker Summit 2017

Mon, 20 Mar 2017 08:02:00 EDT

MONMOUTH JUNCTION, NJ--(Marketwired - March 20, 2017) - DiamiR, a developer of innovative minimally invasive diagnostic tests for neurodegenerative and other diseases, today announced that Kira Sheinerman, PhD, Chief Executive Officer, will be presenting at the GTCbio Biomarker Summit, 6th Neurological Biomarkers Conference being held March 20-22, 2017 at the Hilton San Diego Resort & Spa in San Diego, California.




MJTV More Than Doubles The Number Of Units Of LUNA Sold In The First Quarter Of 2017

Mon, 20 Mar 2017 08:00:00 EDT

WHIPPANY, NJ--(Marketwired - Mar 20, 2017) - Michael James Enterprises, Inc. (OTCQB: MJTV), is pleased to report that the company has more than doubled the number of units sold of its first product LUNA. MJTV bottled up 50 units of LUNA and offered it for sale at a promotional price of $20 in the fourth quarter of 2016. Slight product mixture changes and labeling were made and presented at a few local events in New York over a few week period recently resulting in the product completely selling out and becoming back ordered.




New Info-Rich Data Code on AseptiQuik(R) Connectors

Mon, 20 Mar 2017 08:00:00 EDT

A quick scan yields a wealth of critical, useful information for biopharma users




Oryzon to Present at the Sachs Associates 2nd Annual Neuroscience BioPartnering & Investment Forum

Mon, 20 Mar 2017 08:00:00 EDT

BARCELONA, SPAIN and CAMBRIDGE, MA--(Marketwired - March 20, 2017) - Oryzon Genomics (ISIN Code: ES0167733015, ORY), a public clinical-stage biopharmaceutical company leveraging epigenetics to develop therapies in diseases with strong unmet medical need, announced today that Dr. Carlos Buesa, Oryzon's Chief Executive Officer, is scheduled to present at the SACHS Associates 2nd Annual Neuroscience BioPartnering & Investment Forum, being held March 27, 2017 at the New York Academy of Sciences in New York City.




ViaDerma Receives Provisional Patent Numbers for Its FDA Registered Viabecline and Cannabis Technologies, and Seeks to Distribute its Products with a Management, Marketing and Distribution Company in Canada to Approved International Cannabis Countries

Mon, 20 Mar 2017 08:00:00 EDT

The Company will Target Countries where Medical and Recreational Cannabis Sales are Legal and Accepted and Scientific Research is Allowed




Emblem Sees Significant Rise in Patient Acquisition

Mon, 20 Mar 2017 07:30:00 EDT

PARIS, ONTARIO--(Marketwired - March 20, 2017) -




Combination Product Regulatory Requirement Complexities and the Impact of the 21st Century Cures Act, New Webinar Hosted by Xtalks

Mon, 20 Mar 2017 07:30:00 EDT

TORONTO, ON--(Marketwired - March 20, 2017) - In a special presentation, Diane Beatty, PhD, Managing Director of Regulatory Affairs and Product Development and Jean Dehdashti, MSc, RAC, Scientist III Regulatory Affairs & Product Development both from Cardinal Health Regulatory Sciences will discuss their experience with the regulatory and product development processes for combination products to show you how to navigate regulatory complexities. The live broadcast takes place on Wednesday, April 5, 2017 at 2pm EDT.




Cell Therapy -- Achieving Success on the Road to Commercialization, New Webinar Hosted by Xtalks

Mon, 20 Mar 2017 07:00:00 EDT

TORONTO, ON--(Marketwired - March 20, 2017) - During an informative session on Wednesday, April 5, 2016, industry experts from Fisher BioServices, Kristen Franklin, Client Services Manager and Amy Hendricks, Project Manager will review some of the key components to consider when developing a strategy to minimize risk, manage cost, and ultimately deliver a product to market.




Aevi Genomic Medicine Provides Top-line Results from the SAGA Trial of AEVI-001

Mon, 20 Mar 2017 07:00:00 EDT

PHILADELPHIA, PA--(Marketwired - Mar 20, 2017) -




Dynavax Announces Upcoming Data Presentations for Three TLR9 Agonist Programs at the 2017 American Association for Cancer Research Annual Meeting

Mon, 20 Mar 2017 06:00:00 EDT

BERKELEY, CA--(Marketwired - March 20, 2017) - Dynavax Technologies Corporation (NASDAQ: DVAX) announced today that it will be presenting data on three programs based on stimulation of the immune response using Toll-Like Receptor 9 (TLR9) agonists at the 2017 American Association for Cancer Research Annual Meeting in Washington, D.C. from April 1-5, 2017.




Opthea Receives Positive Feedback from European Regulatory Agencies for the OPT-302 Clinical Program in wet AMD

Mon, 20 Mar 2017 05:30:00 EDT

MELBOURNE, AUSTRALIA--(Marketwired - Mar 20, 2017) - Opthea Limited (ASX: OPT), a developer of novel biologic therapies for the treatment of eye diseases, has concluded positive European scientific advice meetings with the United Kingdom's (UK) Medicines and Healthcare Products Regulatory Agency (MHRA) and Sweden's Medical Products Agency (MPA) for the clinical development program of OPT-302, Opthea's novel VEGF-C/D 'Trap' therapy for the treatment of wet age-related macular degeneration (wet AMD).




Diet Doc Offer Nutritional Counseling For Long-Term Weight Loss Success With Mediterranean Diet

Mon, 20 Mar 2017 01:00:00 EDT

PARKERSBURG, WV--(Marketwired - March 20, 2017) - Choosing a healthy and affordable diet is more challenging than ever with the surplus of weight loss options in the market. While the American obesity rate has nearly reached 35%, the weight loss market has exceeded $64 billion. With emotional eating and inactive lifestyles leading to unprecedented levels of weight gain, obesity levels may not decline anytime soon. More than ever, making an educated dietary choice is important.